Cargando…

Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells

BACKGROUND: During the female reproductive cycle, follicular development and corpus luteum formation crucially depend on the fast generation of new blood vessels. The importance of granulosa cells and follicular fluid in controlling this angiogenesis is still not completely understood. Vascular endo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruemmer, Ruth, Motejlek, Karin, Berghaus, Daniela, Weich, Herbert A, Neulen, Joseph
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1276815/ https://www.ncbi.nlm.nih.gov/pubmed/16248895 http://dx.doi.org/10.1186/1477-7827-3-57

Ejemplares similares

Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases
por: Jung, Jae-Joon, et al.
Publicado: (2012)

Correction: Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases
por: Jung, Jae-Joon, et al.
Publicado: (2012)

Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing
por: Ikeda, Takayuki, et al.
Publicado: (2011)

A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells
por: Kinghorn, Karina, et al.
Publicado: (2023)

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy
por: Zhai, Yaling, et al.
Publicado: (2020)

Elevated Soluble VEGF Receptor sFlt-1 Correlates with Endothelial Injury in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2014)

Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human Placenta
por: Nevo, Ori, et al.
Publicado: (2013)

Release of soluble vascular endothelial growth factor receptor-1 (sFlt-1) during coronary artery bypass surgery
por: Denizot, Yves, et al.
Publicado: (2007)

Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients
por: Zarychta, Elżbieta, et al.
Publicado: (2023)

Mechanical Forces Induce Changes in VEGF and VEGFR-1/sFlt-1 Expression in Human Chondrocytes
por: Beckmann, Rainer, et al.
Publicado: (2014)

An Increase in Vascular Endothelial Growth Factor (VEGF) and VEGF Soluble Receptor-1 (sFlt-1) Are Associated with Early Recurrent Spontaneous Abortion
por: Pang, Lihong, et al.
Publicado: (2013)

PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GIST
por: Hansson, E K, et al.
Publicado: (2013)

Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia
por: Charnock-Jones, D. Stephen
Publicado: (2016)

Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus
por: Yuan, Zhi-Chao, et al.
Publicado: (2020)

The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice
por: Zhao, Guangxian, et al.
Publicado: (2017)

Blood Vessel Patterning on Retinal Astrocytes Requires Endothelial Flt-1 (VEGFR-1)
por: Chappell, John C., et al.
Publicado: (2019)

AAV8-mediated sVEGFR2 and sVEGFR3 gene therapy combined with chemotherapy reduces the growth and microvasculature of human ovarian cancer and prolongs the survival in mice
por: Kujala, Anni, et al.
Publicado: (2022)

Differential regulation of sFlt-1 splicing by U2AF65 and JMJD6 in placental-derived and endothelial cells
por: Eddy, Adrian C., et al.
Publicado: (2020)

Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
por: Miyashita, Hiroki, et al.
Publicado: (2011)

Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase
por: Oe, Yuji, et al.
Publicado: (2018)

Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
por: Garvin, S, et al.
Publicado: (2005)

Soluble VEGF receptor 1 (sFLT1) induces non-apoptotic death in ovarian and colorectal cancer cells
por: Miyake, Tatsuya, et al.
Publicado: (2016)

Alterations of plasma nitric oxide, vascular endothelial growth factor, and soluble form of its receptor (sFlt-1) after resistance exercise: An experimental study
por: Esfahanni, Parivash Shekarchizadeh, et al.
Publicado: (2014)

Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction – implications for treating preeclampsia
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2018)

Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta
por: Brownfoot, Fiona C., et al.
Publicado: (2016)

Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
por: Ahmad, Shakil, et al.
Publicado: (2011)

Human umbilical cord mesenchymal stem cell derived exosomes (HUCMSC-exos) recovery soluble fms-like tyrosine kinase-1 (sFlt-1)-induced endothelial dysfunction in preeclampsia
por: Chang, Xinwen, et al.
Publicado: (2023)

sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Spearman, Andrew D., et al.
Publicado: (2021)

sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023)

Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
por: Gurnadi, Jeffry Iman, et al.
Publicado: (2015)

Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis
por: Dumnicka, Paulina, et al.
Publicado: (2016)

sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection
por: Greco, Marilena, et al.
Publicado: (2021)

Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas
por: Norgall, Susanne, et al.
Publicado: (2007)

RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018)

sFlt-1 in Chronic Kidney Disease: Friend or Foe?
por: Matsui, Masaru, et al.
Publicado: (2022)

Alterations in plasma soluble vascular endothelial growth factor receptor-1 (sFlt-1) concentrations during coronary artery bypass graft surgery: relationships with post-operative complications
por: Denizot, Yves, et al.
Publicado: (2008)

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use
por: Wu, Florence T H, et al.
Publicado: (2010)

Commentary: sVEGFR1 Is Enriched in Hepatic Vein Blood—Evidence for a Provisional Hepatic Factor Candidate?
por: Putotto, Carolina, et al.
Publicado: (2021)

Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study
por: Şalk, Sultan, et al.
Publicado: (2022)

Production of an anti-angiogenic factor sFLT1 is suppressed via promoter hypermethylation of FLT1 gene in choriocarcinoma cells
por: Sasagawa, Tadashi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k40cbm263vb6fsavjn6bb9s3s